• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中与突触核蛋白病相关的发病机制及脑源性神经营养因子的潜力。

Synucleinopathy-associated pathogenesis in Parkinson's disease and the potential for brain-derived neurotrophic factor.

作者信息

Miller Kathryn M, Mercado Natosha M, Sortwell Caryl E

机构信息

Department of Translational Neuroscience, College of Human Medicine, Michigan State University, Grand Rapids, MI, USA.

Neuroscience Graduate Program, College of Natural Science, Michigan State University, East Lansing, MI, USA.

出版信息

NPJ Parkinsons Dis. 2021 Apr 12;7(1):35. doi: 10.1038/s41531-021-00179-6.

DOI:10.1038/s41531-021-00179-6
PMID:33846345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8041900/
Abstract

The lack of disease-modifying treatments for Parkinson's disease (PD) is in part due to an incomplete understanding of the disease's etiology. Alpha-synuclein (α-syn) has become a point of focus in PD due to its connection to both familial and idiopathic cases-specifically its localization to Lewy bodies (LBs), a pathological hallmark of PD. Within this review, we will present a comprehensive overview of the data linking synuclein-associated Lewy pathology with intracellular dysfunction. We first present the alterations in neuronal proteins and transcriptome associated with LBs in postmortem human PD tissue. We next compare these findings to those associated with LB-like inclusions initiated by in vitro exposure to α-syn preformed fibrils (PFFs) and highlight the profound and relatively unique reduction of brain-derived neurotrophic factor (BDNF) in this model. Finally, we discuss the multitude of ways in which BDNF offers the potential to exert disease-modifying effects on the basal ganglia. What remains unknown is the potential for BDNF to mitigate inclusion-associated dysfunction within the context of synucleinopathy. Collectively, this review reiterates the merit of using the PFF model as a tool to understand the physiological changes associated with LBs, while highlighting the neuroprotective potential of harnessing endogenous BDNF.

摘要

帕金森病(PD)缺乏疾病修饰治疗方法,部分原因是对该疾病病因的理解不完整。α-突触核蛋白(α-syn)由于其与家族性和特发性病例的关联,特别是其定位于路易小体(LBs)(PD的一种病理标志),已成为PD研究的一个焦点。在这篇综述中,我们将全面概述将突触核蛋白相关路易病理与细胞内功能障碍联系起来的数据。我们首先介绍在死后人类PD组织中与路易小体相关的神经元蛋白和转录组的变化。接下来,我们将这些发现与体外暴露于α-突触核蛋白预制纤维(PFFs)引发的类路易小体包涵体相关的发现进行比较,并强调该模型中脑源性神经营养因子(BDNF)显著且相对独特的减少。最后,我们讨论BDNF可能对基底神经节发挥疾病修饰作用的多种方式。尚不清楚的是,在突触核蛋白病的背景下,BDNF减轻包涵体相关功能障碍的潜力。总的来说,这篇综述重申了使用PFF模型作为理解与路易小体相关的生理变化的工具的价值,同时强调了利用内源性BDNF的神经保护潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e10c/8041900/480b3b5b7269/41531_2021_179_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e10c/8041900/480b3b5b7269/41531_2021_179_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e10c/8041900/480b3b5b7269/41531_2021_179_Fig1_HTML.jpg

相似文献

1
Synucleinopathy-associated pathogenesis in Parkinson's disease and the potential for brain-derived neurotrophic factor.帕金森病中与突触核蛋白病相关的发病机制及脑源性神经营养因子的潜力。
NPJ Parkinsons Dis. 2021 Apr 12;7(1):35. doi: 10.1038/s41531-021-00179-6.
2
Striatal Afferent BDNF Is Disrupted by Synucleinopathy and Partially Restored by STN DBS.纹状体传入性脑源性神经营养因子受神经核团刺激术调控的异常与帕金森病相关。
J Neurosci. 2021 Mar 3;41(9):2039-2052. doi: 10.1523/JNEUROSCI.1952-20.2020. Epub 2021 Jan 20.
3
Quality Over Quantity: Advantages of Using Alpha-Synuclein Preformed Fibril Triggered Synucleinopathy to Model Idiopathic Parkinson's Disease.质量胜于数量:使用α-突触核蛋白预形成纤维引发突触核蛋白病来模拟特发性帕金森病的优势。
Front Neurosci. 2018 Sep 4;12:621. doi: 10.3389/fnins.2018.00621. eCollection 2018.
4
Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.向大鼠脑内纹状体注射预先形成的小鼠α-突触核蛋白原纤维会引发α-突触核蛋白病变和双侧黑质纹状体变性。
Neurobiol Dis. 2015 Oct;82:185-199. doi: 10.1016/j.nbd.2015.06.003. Epub 2015 Jun 17.
5
Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils.纹状体内α-突触核蛋白原纤维引发的突触核蛋白病大鼠模型中α-突触核蛋白包涵体形成和黑质纹状体变性的时程和程度。
Neurobiol Dis. 2019 Oct;130:104525. doi: 10.1016/j.nbd.2019.104525. Epub 2019 Jul 2.
6
Unbiased Proteomics of Early Lewy Body Formation Model Implicates Active Microtubule Affinity-Regulating Kinases (MARKs) in Synucleinopathies.早期路易小体形成模型的无偏蛋白质组学表明,活性微管亲和力调节激酶(MARKs)与突触核蛋白病有关。
J Neurosci. 2017 Jun 14;37(24):5870-5884. doi: 10.1523/JNEUROSCI.2705-16.2017. Epub 2017 May 18.
7
Modeling Parkinson's disease pathology in human dopaminergic neurons by sequential exposure to α-synuclein fibrils and proinflammatory cytokines.通过依次暴露于α-突触核蛋白原纤维和促炎细胞因子在人多巴胺能神经元中模拟帕金森病病理学。
Nat Neurosci. 2024 Dec;27(12):2401-2416. doi: 10.1038/s41593-024-01775-4. Epub 2024 Oct 8.
8
Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve.将α-突触核蛋白原纤维注入小鼠胃肠道会通过迷走神经在脑干中诱导出类似路易小体的聚集物。
Mol Neurodegener. 2018 May 11;13(1):21. doi: 10.1186/s13024-018-0257-5.
9
NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.自然杀伤细胞清除α-突触核蛋白,而 NK 细胞耗竭会加剧α-突触核蛋白病小鼠模型中的突触核蛋白病理。
Proc Natl Acad Sci U S A. 2020 Jan 21;117(3):1762-1771. doi: 10.1073/pnas.1909110117. Epub 2020 Jan 3.
10
Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.β-葡萄糖脑苷脂酶的激活可减少帕金森病患者中脑神经元的病理性α-突触核蛋白并恢复溶酶体功能。
J Neurosci. 2016 Jul 20;36(29):7693-706. doi: 10.1523/JNEUROSCI.0628-16.2016.

引用本文的文献

1
Genotype-Based Housing as a Potential Confounder in Studies Using Transgenic Mouse Models-Insight from the A53T Mouse Model of Parkinson's Disease.在使用转基因小鼠模型的研究中,基于基因型的饲养作为一个潜在混杂因素——来自帕金森病A53T小鼠模型的见解。
Biomedicines. 2025 Jun 19;13(6):1506. doi: 10.3390/biomedicines13061506.
2
Mitochondrial stress disassembles nuclear architecture through proteolytic activation of PKCδ and Lamin B1 phosphorylation in neuronal cells: implications for pathogenesis of age-related neurodegenerative diseases.线粒体应激通过蛋白激酶Cδ的蛋白水解激活和神经元细胞中核纤层蛋白B1的磷酸化来拆解核结构:对年龄相关性神经退行性疾病发病机制的影响
Front Cell Neurosci. 2025 Apr 17;19:1549265. doi: 10.3389/fncel.2025.1549265. eCollection 2025.
3

本文引用的文献

1
Striatal Afferent BDNF Is Disrupted by Synucleinopathy and Partially Restored by STN DBS.纹状体传入性脑源性神经营养因子受神经核团刺激术调控的异常与帕金森病相关。
J Neurosci. 2021 Mar 3;41(9):2039-2052. doi: 10.1523/JNEUROSCI.1952-20.2020. Epub 2021 Jan 20.
2
Neurotrophic factors for disease-modifying treatments of Parkinson's disease: gaps between basic science and clinical studies.用于帕金森病疾病修饰治疗的神经营养因子:基础科学与临床研究之间的差距
Pharmacol Rep. 2020 Oct;72(5):1195-1217. doi: 10.1007/s43440-020-00120-3. Epub 2020 Jul 22.
3
The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration.
Toward a biological definition of neuronal and glial synucleinopathies.迈向神经元和胶质细胞α-突触核蛋白病的生物学定义。
Nat Med. 2025 Feb;31(2):396-408. doi: 10.1038/s41591-024-03469-7. Epub 2025 Jan 30.
4
OTUD5 Protects Dopaminergic Neurons by Promoting the Degradation of α-Synuclein in Parkinson's Disease Model.在帕金森病模型中,OTUD5通过促进α-突触核蛋白的降解来保护多巴胺能神经元。
Adv Sci (Weinh). 2025 Feb;12(7):e2406700. doi: 10.1002/advs.202406700. Epub 2024 Dec 25.
5
HDAC6 inhibitor-loaded brain-targeted nanocarrier-mediated neuroprotection in methamphetamine-driven Parkinson's disease.载有HDAC6抑制剂的脑靶向纳米载体介导的对甲基苯丙胺诱发帕金森病的神经保护作用
Redox Biol. 2025 Feb;79:103457. doi: 10.1016/j.redox.2024.103457. Epub 2024 Dec 5.
6
Harnessing BDNF Signaling to Promote Resilience in Aging.利用脑源性神经营养因子信号通路促进衰老过程中的恢复力。
Aging Dis. 2024 Nov 27. doi: 10.14336/AD.2024.0961.
7
Unlocking the promise of MANF in diseases: Mechanistic insights and therapeutic potentials.MANF 在疾病中的应用前景:机制见解与治疗潜力。
Mol Biol Rep. 2024 Nov 16;51(1):1160. doi: 10.1007/s11033-024-10111-9.
8
Enhancements in Parkinson's Disease Management: Leveraging Levodopa Optimization and Surgical Breakthroughs.帕金森病管理的进展:利用左旋多巴优化和手术突破
Curr Drug Targets. 2025;26(1):17-32. doi: 10.2174/0113894501319817240919103802.
9
BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy.BDNF/TrkB 激活剂在帕金森病中的作用:一种新的治疗策略。
J Cell Mol Med. 2024 May;28(10):e18368. doi: 10.1111/jcmm.18368.
10
Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils.用预形成原纤维诱导的大鼠早期突触核蛋白病的转录组分析。
NPJ Parkinsons Dis. 2024 Jan 3;10(1):7. doi: 10.1038/s41531-023-00620-y.
路易体的形成过程,而不仅仅是α-突触核蛋白的纤维化,是神经退行性变的主要驱动因素之一。
Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4971-4982. doi: 10.1073/pnas.1913904117. Epub 2020 Feb 19.
4
BDNF as a Promising Therapeutic Agent in Parkinson's Disease.BDNF 作为治疗帕金森病的有希望的治疗剂。
Int J Mol Sci. 2020 Feb 10;21(3):1170. doi: 10.3390/ijms21031170.
5
Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders.α-突触核蛋白是一种 DNA 结合蛋白,可调节 DNA 修复,与路易体疾病有关。
Sci Rep. 2019 Jul 29;9(1):10919. doi: 10.1038/s41598-019-47227-z.
6
Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils.纹状体内α-突触核蛋白原纤维引发的突触核蛋白病大鼠模型中α-突触核蛋白包涵体形成和黑质纹状体变性的时程和程度。
Neurobiol Dis. 2019 Oct;130:104525. doi: 10.1016/j.nbd.2019.104525. Epub 2019 Jul 2.
7
α-Synuclein (αSyn) Preformed Fibrils Induce Endogenous αSyn Aggregation, Compromise Synaptic Activity and Enhance Synapse Loss in Cultured Excitatory Hippocampal Neurons.α-突触核蛋白(αSyn)原纤维诱导内源性αSyn 聚集,损害突触活性并增强培养兴奋性海马神经元中的突触丢失。
J Neurosci. 2019 Jun 26;39(26):5080-5094. doi: 10.1523/JNEUROSCI.0060-19.2019. Epub 2019 Apr 29.
8
Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration.致病的α-突触核蛋白聚集物优先与线粒体结合,并影响细胞呼吸。
Acta Neuropathol Commun. 2019 Mar 14;7(1):41. doi: 10.1186/s40478-019-0696-4.
9
Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease.随机试验:脑内室管膜下区胶质细胞源性神经营养因子治疗帕金森病。
Brain. 2019 Mar 1;142(3):512-525. doi: 10.1093/brain/awz023.
10
The genetic landscape of Parkinson's disease.帕金森病的遗传图谱。
Rev Neurol (Paris). 2018 Nov;174(9):628-643. doi: 10.1016/j.neurol.2018.08.004. Epub 2018 Sep 21.